Streetbeat News

MRT

Marti Technologies, Inc.

https://www.marti.tech

Industry

Software - Application

Marti Technologies Inc. provides urban transportation services to riders in Turkey. It also operates a mobility app that provides multiple transportation services to its riders; and operates a fleet of e-mopeds, e-bikes, and e-scooters. The company was founded in 2018 and is based in Istanbul, Turkey.

Open

3.24

Mkt cap

187M

Volume

36K

High

3.32

P/E Ratio

-4.53

52-wk high

3.89

Low

3.23

Div yield

N/A

52-wk low

0.71

Monte Rosa Therapeutics is leveraging its proprietary QuEEN platform and AI to design new molecular glue degraders. The company has secured partnerships with Roche and Novartis, providing non-dilutive funding and validating its technology. Key data from its pipeline, including MRT‑2359, MRT‑6160, and MRT‑8102, is expected in 2025.

Portfolio Pulse from

February 17, 2025 | 1:45 am

Marti Technologies, Inc. is positioned as a 'Strong Buy' in Turkey's ride-hailing market, with a share price of $3.54 and a market cap of $207 million. The company is expected to achieve significant revenue growth, positive EBITDA, and free cash flow by 2025, driven by expanded services and operational efficiencies.

Portfolio Pulse from

January 13, 2025 | 4:45 am

Marti has achieved significant growth with 1.6 million riders and 255,000 drivers, marking a 15% increase in rides over six months. The company is positioned to capture a $2 billion revenue potential within a $9–$12 billion total addressable market (TAM). Marti's driver subscription model suggests an initial revenue potential of $800 million.

Portfolio Pulse from

December 24, 2024 | 3:30 pm

Marti Technologies, Inc. (NYSE American: MRT) has surpassed its year-end targets for its ride-hailing service, reaching 1.61 million riders and 255 thousand registered drivers by December 15, 2024. This achievement comes half a month earlier than planned, with a 15% increase in riders since September 30, 2024.

Portfolio Pulse from

December 16, 2024 | 11:15 am

Monte Rosa Therapeutics announced progress in its Phase 1/2 study of MRT-2359 for MYC-driven solid tumors, showing a favorable safety profile and determining a recommended Phase 2 dose. Further results are expected in Q1 2025.

Portfolio Pulse from

December 05, 2024 | 12:15 pm

Marti Technologies, Inc. (NYSE American: MRT), Türkiye's leading mobility super app, expects to achieve positive free cash flow by 2025. The company has started monetizing its ride-hailing service after two years of investment.

Portfolio Pulse from

December 02, 2024 | 11:45 am

SIMPPLE Ltd. has announced the sale and deployment of 89 autonomous cleaning robots across three major MRT lines in Singapore, operated by SMRT Trains. This marks the largest robotic fleet in the land transport sector.

Portfolio Pulse from

November 22, 2024 | 1:45 pm

Portfolio Pulse from

November 22, 2024 | 1:45 pm

Marti Technologies, Inc. (NYSE:MRT) has appointed Deniz Terlemez as the new Interim Chief Financial Officer, effective November 1, 2024. Terlemez, previously the Finance Director, succeeds Oguz Erkan.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:05 pm

Marti Technologies has extended its share repurchase program for six months, allowing the repurchase of up to $2.5 million in shares. The ceiling price for the buyback has been amended from $3.30 to $5.00 per share.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:05 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.